Brookline Capital Acquisition Corp WT (BCACW)
Brookline Capital Acquisition Corp WT
(BCACW)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCACW | BDRX | NCNA | ||
| Company | Brookline Capital Acquisition Corp WT | Biodexa Pharmaceuticals Plc ADR | Nucana Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2450 | 1.3100 | 2.27 | ||
| High | 0.6799 | 1.3700 | 2.28 | ||
| Low | 0.2450 | 1.2500 | 2.22 | ||
| Latest | 0.5500 | 1.2700 | 2.23 | ||
| Change | +0.3100 | -0.0300 | -0.02 | ||
| % Change | +129.17% | -2.31% | -0.89% | ||
| Volume | 901,100 | 125,400 | 25,800 | ||
| 20-Day Average Volume | 59,175 | 520,050 | 93,050 | ||
| Previous Close | 0.2400 | 1.3000 | 2.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1819 | 1.8705 | 2.84 | ||
| 20-Day Raw Stochastic | 77.37% | 4.35% | 9.20% | ||
| 20-Day Relative Strength | 84.53 | 35.16 | 30.56 | ||
| Weighted Alpha | -69.67 | -95.73 | -88.72 | ||
| Today's Opinion | 8% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 96% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.42% since 07/22/22 | -22.09% since 02/03/26 | -7.08% since 02/03/26 | ||
| Low | 0.1500 on 07/25/22 | 1.2200 on 02/06/26 | 2.07 on 02/05/26 | ||
| High | 0.6799 on 07/29/22 | 1.6300 on 02/04/26 | 2.45 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +358.33% since 06/28/22 | -45.96% since 01/09/26 | -33.83% since 01/09/26 | ||
| Low | 0.1002 on 06/30/22 | 1.2200 on 02/06/26 | 2.07 on 02/05/26 | ||
| High | 0.6799 on 07/29/22 | 2.3700 on 01/13/26 | 3.81 on 01/13/26 | ||
| 3-Month | |||||
| %Chg | +292.86% since 04/29/22 | -76.22% since 11/10/25 | -39.24% since 11/10/25 | ||
| Low | 0.0600 on 05/12/22 | 1.2200 on 02/06/26 | 2.07 on 02/05/26 | ||
| High | 0.6799 on 07/29/22 | 8.9400 on 12/10/25 | 4.55 on 12/10/25 | ||
| 6-Month | |||||
| %Chg | +52.78% since 01/28/22 | -82.19% since 08/08/25 | -65.37% since 08/08/25 | ||
| Low | 0.0600 on 05/12/22 | 1.2200 on 02/06/26 | 2.07 on 02/05/26 | ||
| High | 0.6799 on 07/29/22 | 11.8800 on 10/09/25 | 7.22 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 866 | 68 | ||
| Shares Outstanding, K | N/A | 682 | 30 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -480,000 | -7,320,000 | -24,280,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -2,457,658 | N/A | -380,000 | ||
| 60-Month Beta | N/A | 1.01 | 1.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.10 on 11/13/25 | ||
| Latest Earnings Date | 01/01/70 | 04/10/26 | 03/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||